Surgical Science Sweden Ab Stock Forecast

Buy or Hold candidate since May 14, 2026 Gain 39.86%

No changes to the price of Surgical Science Sweden AB stock on the last trading day (Tuesday, 23rd Jun 2026). During the last trading day the stock fluctuated 0% from a day low at $4.00 to a day high of $4.00. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 52.69% during the next 3 months and, with a 90% probability hold a price between $5.54 and $7.09 at the end of this 3-month period.

SUSRF Signals & Forecast

The Surgical Science Sweden AB stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.00 and $3.61. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, May 22, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Surgical Science Sweden AB stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $3.76 (-6.00%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 20 days ago.)

Trading Expectations (SUSRF) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Surgical Science Sweden AB to open at $4.00, and during the day (based on 14 day Average True Range), to move between $3.99 and $4.01, which gives a possible trading interval of +/-$0.0218 (+/-0.55%) up or down from last closing price. If Surgical Science Sweden AB takes out the full calculated possible swing range there will be an estimated 0.55% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $4.09, some $0.0900 (2.25%) from the current price of $4.00, our system finds the risk reward not very attractive.

Is Surgical Science Sweden AB stock A Buy?

Surgical Science Sweden AB holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $4.00 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk